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1. Introduction 
The role of echocardiography in patients with atrial fibrillation (AF) has been changing 
gradually according with recent advance in echocardiographic instruments and better 
understanding for AF. Historically, M-mode echocardiography applied to AF patients has 
focused on the diagnosis of underlying organic heart diseases and on the detection of left 
atrial (LA) thrombi. These are not surprising because AF had been the highest risk of 
ischemic stroke in the era of incomplete anticoagulation therapy. Thereafter, LA size, 
volume and functions have been foci assessed by echocardiography. These 
echocardiographic procedures have been conducted for prediction and prevention of 
recurrence of AF paroxysms (Barbier et al, 1994; Verdecchia et al, 2003; Vasan et al, 2003). 
Spontaneous echo contrast has also been an established B-mode echocardiographic finding 
with highly predictive value of ischemic stroke. After the development of Doppler 
echocardiography, pulmonary venous flow (PVF) evaluation is a routine laboratory 
investigation for patients with and without AF. The usefulness of PVF evaluation is not 
limited to assess LA or left ventricular (LV) functions, but has expanded to investigation of 
various aspects of AF (Tabata et al., 2003). PVF recording increases its usefulness when it is 
combined with recordings of Doppler LV inflow pattern. This article reviews the established 
usefulness of PVF estimation in patients with permanent AF, and then focuses on the 
potential usefulness of PVF assessment in AF progression, i.e., during sinus rhythm (i.e., 
interval of paroxysms of AF), during ongoing paroxysmal AF, and further during the long-
term AF management. 
2. Clinical Perspectives of AF 
AF is one of the most common sustained arrhythmias in daily clinical practice. There has 
been a great advance in the exploration of the etiologies of AF. These are the subject of 
several overlapping schemes of individual pathogenesis, i.e., atrial overload and stretch, 
myocardial ischemia and inflammation, degeneration and subsequent fibrosis of atrial 
myocardium, neurohumoral or metabolic factors, and other unknown factors. Therefore, 
clinical presentations of AF are very broad. This arrhythmia occurs in a variety of clinical 
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settings such as valvular heart diseases, postoperative conditions, heart failure, 
hypertension, metabolic syndrome, thyrotoxicosis, and so on (Fig. 1). Since valvular heart 
diseases were historically a main etiology of AF, echocardiographic attention to AF patients 
was mainly rheumatic valvular lesions and detection of LA thrombi or spontaneous echo 
contrast which is based on the local hemostatic changes due to rheologic abnormalities 
(Kwaan et al, 2004; Topaloglu et al, 2007). In relation to thrombus formation, LA appendage 
function was highlighted in that impaired appendage function leads to thrombus formation 
and high risk of embolic event (Donal et al, 2005). According to an increased prevalence of 
coronary artery diseases, AF has been encountered in acute myocardial infarction, after 
coronary artery bypass grafting surgery and chronic phase of ischemic heart disease and 
subsequent heart failure. On the other hand, AF is often observed in patients with another 
kind of arrhythmias (e.g., preexcitation syndrome) or noncardiac disorders (e.g., 
thyrotoxicosis, chronic obstructive pulmonary disease). AF is often encountered in subjects 
without systemic or organic heart diseases (so-called ‘lone’ AF). According with relative 
decline of rheumatic valvular diseases, terminology of ‘nonvalvular’ or ‘nonrheumatic’ AF 
becomes familiar. Wide spectrum in clinical features of AF sometimes makes the therapeutic 
decision-making difficult (Wyse & Gersh, 2004). 
AF is classified by the duration in which this arrhythmia sustains (e.g., paroxysmal, 
persistent and permanent). Paroxysmal AF is characterized as rare or repetitive paroxysms 
of short-lasting AF, which often undergoes spontaneous conversion to sinus rhythm, but 
rhythm-control treatment is required depending on symptom and hemodynamic 
deterioration. Persistent AF has the possibility of termination either by antiarrhythmic drugs 
or by electrical defibrillation. Permanent AF does not restore to sinus rhythm 
spontaneously, and hence conservative therapeutic option is the rate-control strategy. AF is 
not only responsible for substantial morbidity and mortality, but also impairs quality of life 
by limited capacities of physical activity and heart rate regulation. To date, the most 
effective treatment for drug-refractory AF is radiofrequency catheter ablation. Pulmonary 
vein (PV) isolation by circumferential ablation of PV-LA junction is a promising technique to 
terminate AF. Despite the introduction of novel and sophisticated ablation techniques such 
as irrigation catheters, pericardial approach and ganglionated plexi ablation, periprocedural 
complications are not negligible. 
AF is characterized to date as an age-dependent, progressive disease, i.e., AF prevalence 
increases steeply from 0.5% at age 50 to 59 years to 9.0% at age 80 to 89 years (Kannel et al., 
1998). Progressive nature of this arrhythmia is evident in that AF becomes refractory to 
pharmacologic treatment and electrical defibrillation in proportion with the duration of 
sustaining AF. This is the main feature that distinguishes AF from many other kinds of 
clinical arrhythmia (Wijffels et al., 1995). In a few decades, the mechanisms of such 
progression of AF have been clarified by many basic experiments using AF animal models 
and clinical studies of AF patients. Remodeling of LA plays an important role in the genesis, 
maintenance and perpetuation of AF. LA remodeling is a concept including electrical, 
contractile and structural aspects. Electrical remodeling induces abbreviated and dispersed 
electrical refractoriness and inhomogeneous slow conduction of electrical impulse. These are 
considered to be an arrhythmogenic substrate, prerequisite of AF development. 
Electrocardiograms (ECG) in patients with AF demonstrate characteristic fibrillation (f) 
waves that are evident in right precordial leads. According to the progression of AF, 
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characteristic f-waves become gradually small in amplitude and high in frequency. On the 
other hand, contractile remodeling provides poor LA contraction and structural remodeling 
causes LA dilatation. Histologically, LA myocardium in patients with AF shows infiltration 
of inflammatory cells, interstitial fibrosis and loss of contractile myocytes, leading to slow, 
fragmented and fibrillatory conduction and poor dyssynchronous LA contractions. 
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Fig. 1. Mechanisms favoring atrial fibrillation (AF).  
3. Physiology of PVF 
PVF recording is feasible not only by transesophageal echocardiography (TEE) but also by 
transthoracic echocardiography (TTE). According with the prevalence of PVF estimation by 
TTE, there have been investigations comparing the PVF recorded by TTE with that recorded 
by TEE. To date, TTE estimation of PVF is reported to provide reliable quantitation of PVF 
recorded by TEE in patients with and without organic heart diseases (Masuyama et al., 
1995).  Fig. 2 is an actual Doppler PVF pattern during an entire cardiac cycle recorded by 
TTE. When ultrasound probe is positioned at the apex of chest wall, a four-chamber apical 
view is obtained. Then color jet is visualized in the upper LA of real-time, B-mode image. 
This color image is forward blood flow signals in right superior PV (Fig. 2, upper). After 
overall color Doppler interrogation, Doppler velocimetry is obtained by positioning the 
sampling gate 2-3 cm distal from the orifice of right superior PV (Fig. 2, lower). 
The PVF profile is characterized as forward flows during LV systolic (S) and early diastolic 
(D) phases, and as reversed flow during late diastole when LA contracts (Ar). There are 
strictly two components within the S wave of PVF, i.e., S1 is caused by active LA relaxation 
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and S2 is ascribed to passive LA wall stretching caused by vigorous LV contraction toward 
apical direction. Peak velocity and velocity-time integral of the S wave are usually greater 
than those of the D wave. Gentile et al (1997) investigated Doppler PVF parameters in 143 
healthy individuals aged from 20 to 80 years by TTE. Age-dependent Doppler parameters 
are reported to be as follows; peak amplitude and time integral of both S and D waves, and 
S/D peak amplitude and integral ratios, whereas Ar wave is reported to be age-
independent. These findings indicate the possibility of Ar wave as a diagnostic tool of 
various hemodynamic abnormalities in a wide range of patients’ age. 
S D
Ar
 
Fig. 2. Representative Doppler imaging of transthoracic echocardiography applied to a 
patient with hypertension. Upper image is an apical four chamber view with color flow 
indicating blood flow returning from right superior pulmonary vein (PV) into left atrium 
(LA). Middle is an ECG tracing (standard limb lead II). Lower is a continuous-wave Doppler 
PV flow velocimetry during an entire cardiac cycle. Upward direction indicates forward 
flow, whereas downward direction means reverse flow. 
LA plays three different roles periodically in an entire cardiac cycle, i.e., LA acts as a 
‘booster pump’ when LA contracts in late LV diastole, then as a ‘reservoir’ during LV 
systole, and finally as a ‘conduit’ during early LV diastole (Fig. 3). These three kinds of LA 
functions correspond with Ar, S and D waves respectively, and are estimated also by LA 
volume curve during an entire cardiac cycle using automatic boundary detection (Zhang et 
al, 1998), manual tracking (Ogawa et al, 2009), and speckle tracking techniques (Mori et al, 
2011). The PVF pattern, especially S and D wave components, is influenced originally by 
many physiologic factors such as age, heart rate, respiration, LV function and loading 
conditions (Bollmann, 2007). These factors should be taken into account when evaluating 
PVF recording. 
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Fig. 3. Illustration of normal blood flow pattern in PV and LA during an entire cardiac cycle. 
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4. Myocardial sleeves in PV 
In the PVF profile, Ar wave reflects physiologic PV regurgitation during LA contraction due 
to the absence of an anatomic valve at the PV-LA junction. Interestingly, PV wall contains 
myocardial sleeves instead of anatomic valve. Fig. 4 is a schematic illustration of human 
atria and adjacent great veins. Posterior LA wall contains complicated myocardial layers for 
myocardial sleeves running longitudinally, cross-sectionally and obliquely within the PV 
walls. Histologically, myocardial sleeves exist in the mid-layer of PV walls (Fig. 5A). The 
myocardial sleeves are, therefore, considered to function as a ‘sphincter’, which minimizes 
the PV regurgitation caused by LA contraction. PV contraction is actually confirmed, and 
this phenomenon is mainly due to the presence of myocardial sleeves contracting 
synchronously with LA myocardium. This is validated by radiofrequency catheter ablation, 
i.e., perfect PV isolation (e.g., electrical disconnection of PV-LA junction) is reported to 
abolish the PV contraction (Atwater et al, 2011). These sleeves also function as ‘throttle’ 
valve that regulates cardiac output for systemic circulation (Burch & Romney, 1954). The 
myocardial sleeves show characteristic electrophysiological properties prone to yield 
spontaneous repetitive firings which propagate to LA and cause frequent ectopic beats. Fig. 
5B is the microelectrode recording of the intracellular potentials of guinea-pig LA and 
myocardial sleeve in PV. Resting membrane potential in myocardial sleeve is less negative 
relative to that of LA. Moreover, myocardial sleeve in PV show the tendency of spontaneous 
electrical activity leading to the abnormal automaticity initiating AF. These arrhythmogenic 
foci act as a ‘driver’ to trigger and maintain paroxysms of AF. Highly compliant PV wall 
allows own cyclic stretching due to physiological PV regurgitation. This phenomenon is 
considered to accentuate intracellular Ca2+ dynamics mediated by stretch-activated ion 
channels, which is a prerequisite of repetitive electrical firing (de Bakker et al., 2002; Honjo 
et al., 2003; Chou et al., 2005, Takahara et al, 2011). Moreover, the myocardial sleeves within 
PV show a complicated anisotropic orientation of myocardial fibers separated by fibrotic 
tissues causing impaired electrotonic interactions, which accentuates intrinsic spontaneous 
firing and triggered activity (Nathan & Eliakim, 1966). 
Since Haïssaguerre et al (1998) demonstrated the ectopic and spontaneous electrical 
activities in the myocardial sleeves located in PV responsible for triggering AF, main stream 
of the AF research has been changed over the past decade, in that recent AF study focused 
on many areas which had not been given much attention. Importance of the myocardial 
sleeves as arrhythmogenic foci in AF is confirmed also in the human postmortem studies. 
Tagawa et al (2001) investigated myocardial sleeve distribution in patients with AF or 
without AF. They showed that the significantly longer distance of sleeves extending to the 
peripheral end of PV in AF patients relative to the distance in control patients was 
confirmed  in inferior but not superior PV. In addition, myocytes in PV of AF patients were 
not uniform and surrounded by fibrous tissues compared with those in controls. Moreover, 
Steiner et al (2006) reported that amyloid deposition and scarring in myocardial sleeves 
tended to be observed more frequently in AF patients relative to control patients. 
Interestingly, the incidence of atrial myocardium extending beyond the PV-LA junction up 
to the PV periphery in all the examined PV specimens is commonly reported to be 88 to 89% 
(Tagawa et al, 2001; Steiner et al, 2006). 
According with an advance of immunohistochemical techniques, autonomic nervous 
innervation in PV has been elucidated. Ganglionated plexi are reported to be abundant 
around the great vessels of the human heart including PV (Armour et al, 1997). 
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Furthermore, both cholinergic and adrenergic nerve endings are found together within a 
single neural plexus of PV, and nerve density is highest in the PV antrum (Tan et al, 2006). 
The physiological meaning of these ganglionated plexi remains to be speculative. 
Considering the ‘throttle’ valve function of myocardial sleeves, ganglionated plexi located in 
PV-LA junctions may play a role of neural control of cardiac output by regulating proximal 
PV tonus. Elevated PV tonus associated with pathological condition such as heart failure 
(e.g., ganglionated plexi out of neural control) may lead to the occasion of acute pulmonary 
edema leading to severe dyspnea or orthopnea. AF per se also shows potential autonomic 
influence (Fig. 1). The correlations between the neural aspect of AF and the ganglionated 
plexi possibly influencing PV tonus or contraction are the subjects of future study. 
5. PVF during ongoing AF 
PVF is visualized by Doppler echocardiography not only in sinus rhythm but also during 
AF. AF is characterized by electrophysiological and mechanical properties such as rapid, 
irregular and fragmented electrical activities and absence of complete LA contraction and 
relaxation. Therefore, PVF during AF is known as loss of Ar wave, blunted S wave and 
relatively dominant D wave. Loss of synchronous LA contraction is reflected by 
disappearance of Ar wave. Similarly, loss of complete LA relaxation causes a delayed onset 
of S wave. 
LAA RAA
 
Fig. 4. Schematic illustration of human atria and adjacent great veins. Myocardial sleeves 
run in PV wall longitudinally, obliquely and cross-sectionally. Myocardial sleeve in superior 
PV is usually longer than that in inferior PV. IVC, inferior vena cava; LAA, left atrial 
appendage; LIPV, left inferior PV; LSPV, left superior PV; RAA, right atrial appendage; 
RIPV, right inferior PV; RSPV, right superior PV; SVC, superior vena cava. 
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Fig. 5. A: Microscopic findings of PV obtained from guinea pig (upper: masson trichrome 
staining, lower: immunostaining for α-smooth muscle actin). B: Electrophysiological 
characteristics of PV and LA. (From Takahara, A.; Sugimoto, T.; Kitamura, T.; Takeda, K.; 
Tsuneoka, Y.; Namekata, I. & Tanaka, H. Electrophysiological and pharmacological 
characteristics of triggered activity elicited in guinea-pig pulmonary vein myocardium. 
Journal of Pharmacological Science Vol. 115, No. 2, 2011, pp. 176-181, with permission.) 
A 
B 
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This phenomenon is due to loss of S1 wave that reflects forward PV flow under the active 
LA relaxation. Moreover, early systolic reversed PVF is sometimes observed (Tabata et al., 
2003; Bollmann, 2007). This is reflected by reversed PV-LA pressure gradient at this moment 
of the early systolic phase. S2 per se is also blunted under the increased LA stiffness during 
AF. LA functions of ‘reservoir’ and ’booster pump’ are impaired profoundly under the 
presence of AF. Impaired LA functions result in the reduction of stroke volume by 38% even 
in AF patients without organic heart diseases (Alboni et al, 1995). Therefore, only the 
‘conduit’ function of LA remains, which leads to the greater D wave relative to S2 wave 
(Chao et al., 2000). These echocardiographic findings are important predictors of progressive 
LA remodeling. 
6. PVF during sinus rhythm in AF patients 
AF is a progressive disease showing electrical, contractile and structural LA remodeling 
(Wijffels et al., 1995). It is well known that paroxysms of AF gradually become refractory to 
pharmacologic treatment and electrical defibrillation. Accordingly, paroxysmal AF becomes 
persistent AF, and finally converts to permanent AF, although individual difference in such 
time course exists. For sonographers and cardiologists, one of the greatest 
echocardiographic interests during sinus rhythm in AF patients is to predict future 
paroxysms and progression of AF. Conventionally, prediction of AF progression is based 
mainly on LA size, volume, and functions (Barbier et al, 1994; Verdecchia et al, 2003; Vasan 
et al, 2003). Such evaluations have been performed historically by various 
echocardiographic techniques such as M-mode measurement, LV inflow Doppler 
velocimetry, strain-rate imaging, three-dimensional echocardiography speckle tracking 
technique and so on. Two-dimensional speckle tracking echocardiography monitors LA 
volume curve during an entire cardiac cycle, which enables accurate evaluations of 
aforementioned three kinds of LA functions (e.g., ‘reservoir’, ‘conduit’ and ‘booster pump’ 
functions). This technique showed reduced ‘reservoir’ and ‘booster pump’ functions in 
patients with paroxysmal AF (Mori et al., 2011). 
PVF recording in sinus rhythm of AF patients has been receiving increasing attention, 
because ‘focal’ AF originates predominantly from PV (Haïssaguerre et al., 1998), and wide 
spectrum of paroxysmal to persistent AF associated with and without organic heart diseases 
shows similar characteristics of ‘focal’ AF. PV orifice morphologies in conjunction with AF 
progression have been investigated over the years by various modalities such as TEE 
(Knackstedt et al, 2003), magnetic resonance (MR) imaging (Tsao et al, 2001; Takase et al., 
2004) and multislice computed tomography (Scharf et al, 2003). These investigations have 
been conducted under the uniform hypothesis that largest PV is the main source of ectopic 
electrical activities triggering and sustaining AF. Fig. 6 demonstrates the PV images 
obtained by MR angiography applied to the patients with paroxysmal (Fig. 6A) or 
permanent (Fig. 6B) AF and with sinus rhythm (Fig. 6C). Four PV diameters are reported to 
be greater in the order of patients with permanent AF > those with paroxysmal AF > those 
with sinus rhythm (Takase et al., 2004). Moreover, PV branching pattern observed in AF 
patients is complicated compared with that of patients with sinus rhythm. These indicate 
that most permanent and paroxysmal AF stems from ‘focal’ AF, and that progressive 
structural remodeling caused by AF affects both LA and PV. With respect to the PV/LA 
diameter ratio, there has been a controversy, i.e., this ratio in patients with AF tended to be 
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greater than that of patients without AF (Knackstedt et al, 2003), whereas this ratio was the 
same among the patient groups of paroxysmal AF, permanent AF and sinus rhythm (Tsao et 
al, 2001). These discrepant results may be attributed in part to the different imaging 
modalities and AF patients’ enrollment. 
In spite of accumulated morphological investigations of PV-LA junction in AF patients, 
there have been controversies in echocardiographic PVF patterns during sinus rhythm in 
patients susceptible to AF. Kosmala et al (2006) reported that an abnormal PVF pattern was 
observed in patients with AF, i.e., abbreviated acceleration time and prolonged deceleration 
time in S wave, indicating impaired LA relaxation and compliance. Similarly, Lindgren et al 
(2003) reported the reduced S wave amplitude as a predictor of AF progression. These are 
compatible to the findings reported by two-dimensional speckle tracking method (Mori et 
al, 2011). On the other hand, increased Ar wave amplitude in sinus rhythm is reported to be 
a potential marker of AF progression in hypertensive patients in our laboratory (Fig. 7). Ar 
amplitude and velocity-time integral of Ar wave are supposed to be linked closely to the 
sphincter function of myocardial sleeves located in PV (Fig. 4, Fig. 5A), i.e., impaired 
sphincter function theoretically allows more PV regurgitation and Ar wave augmentation. 
Surprisingly, increased Ar amplitude is associated with reduced, but not increased, LA 
contractility in our study (Maruyama et al, 2008). These findings imply that PV sphincter 
dysfunction is linked to the contractile LA remodeling responsible for AF progression. LA 
contractile performance is usually quantified as LA fractional shortening (LAFS), which is 
calculated by the following equation (Fig. 8), 
 LAFS = (LADa – LADd) / LADa (1) 
where, LADa is an LA diameter at the beginning of LA contraction, and LADd is a 
minimum LA diameter during active LA contraction (Barbier et al, 1994). This is a simple 
measure of LA contractility obtained by M-mode echocardiography, although it is a 
parameter estimated only in the anteroposterior LA direction. Ar wave augmentation is 
associated with reduced LAFS, and predictive values of PV regurgitation (e.g., peak PV 
backflow velocity: PVBV), LA contractile function (e.g., LAFS) and LA size (e.g., LADd) for 
AF progression are assessed. Consequently, receiver-operating curve (ROC) indicated that 
the amplitude of age-independent Ar wave (e.g., PVBV) showed the greatest predictive 
value for the perpetuation of AF (Fig. 9). So far, the reason for discrepant results showing 
the importance of impaired forward flow (S wave) vs. augmented backward flow (Ar wave) 
in AF progression is unknown. PV regurgitation reflected by augmented Ar wave 
amplitude (e.g., PVBV) is determined by LA-PV pressure gradient (e.g., balance between LA 
contractile function and PV ‘sphincter’ function). These structures are under the influence of 
continuous remodeling according to the AF progression, which differs in individual AF 
patient. There are so many echocardiographic indices with different sensitivities and 
specificities. Echocardiography recorded during sinus rhythm at different stages of long-
term AF progression may have resulted in such discrepant outcomes. Therefore, in personal 
opinion, it seems uncertain whether or not such comparisons of echocardiographic 
investigations are meaningful or fruitful. 
Ar  wave augmentation indicating an extent of PV regurgitation is considered to be a PV 
remodeling based on the impaired ‘sphincter’ function of the myocardial sleeves 
www.intechopen.com
 Pulmonary Venous Flow Pattern and Atrial Fibrillation: Fact and Controversy 
 
87 
surrounding the PV-LA junction (Fig. 4, Fig. 5A). This is considered to be due to the 
histological, electrical and mechanical abnormalities of the myocardial sleeves. On the other 
hand, reduced LAFS means the contractile LA remodeling, and increased LADd reflects  
 
 
 
 
Fig. 6. Representative magnetic resonance angiography of patients with paroxysmal (A) or 
permanent (B) AF and with sinus rhythm (C). Diameters of pulmonary veins in AF patients 
are greater than those in patients with sinus rhythm. Landmark (*) showing the center of 
posterior wall of left atrium was indicated. (From Takase, B.; Nagata, M.; Matsui, T.; Kihara, 
T.; Kameyama, A.; Hamabe, A.; Noya, K.; Satomura, K.; Ishihara, M.; Kurita, A. & Ohsuzu, 
F. Pulmonary vein dimensions and variation of branching pattern in patients with 
paroxysmal atrial fibrillation using magnetic resonance angiography. Japanese Heart Journal 
Vol. 45, No. 1, 2004, pp. 81-92, with permission.) 
A B
C
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in part the structural LA remodeling.  It is, therefore, of interest which part of remodeling 
shows the greatest influence on the AF progression and perpetuation. In our study, PV 
remodeling demonstrated the greatest influence on the perpetuation of AF by the ROC 
analysis (Fig. 9). Knackstedt et al (2003) reported no correlation between PV diameter and 
LA size in patients with or without AF. Considering their TEE study, PV remodeling (e.g., 
dilation and regurgitation) plays a key role in AF progression (Scharf et al, 2003), although it 
is uncertain whether PV remodeling is a cause or a consequence of AF progression. PV wall 
is relatively more compliant and hence more susceptible to hemodynamics altered by 
paroxysms of AF than LA wall. Therefore, in personal opinion, these vessel properties of PV 
relates to susceptibility to AF-induced remodeling. 
 
Fig. 7. Representative pulsed-wave Doppler findings of time-matched LV inflow (upper) 
and right superior pulmonary vein (PV) flow patterns (lower) during sinus rhythm in 
patients with AF which became permanent (A) or remained paroxysmal (B). Peak velocity 
of PV backflow (Ar wave) during left atrial (LA) contraction in A (left white arrow) was 
obviously greater than that in B (right white arrow). Time-integral of PV backflow in A is 
also greater than that in B. Note that scale in LV inflow is different from that in PV flow. 
(From Maruyama, T.; Kishikawa, T.; Ito, H.; Kaji, Y.; Sasaki, Y. & Ishihara, Y. Augmentation 
of pulmonary vein backflow velocity during left atrial contraction: a novel phenomenon 
responsible for progression of atrial fibrillation in hypertensive patients. Cardiology Vol. 109, 
No. 1, 2008, pp. 33-40, with permission.) 
After the termination of AF episode, LA contractile function is briefly impaired. This 
impairment is gradually restored, and this reversible phenomenon is well known as LA 
stunning. One of the main causes of this stunning is considered to be based on the intracellular 
handling of cytosolic Ca2+, which is important in cardiac performance but disturbed during 
AF. The aspects of atrial cardiomyopathy induced by tachycardia and atrial hibernation or 
fibrosis are also involved in the genesis of LA stunning (Khan, 2003). Recovery from LA 
A B
www.intechopen.com
 Pulmonary Venous Flow Pattern and Atrial Fibrillation: Fact and Controversy 
 
89 
stunning depends on the duration of AF, mode of defibrillation, and LA size, i.e., AF lasting 10 
to 20 minutes does not cause observable stunning (Sparks et al, 1999) and recovery of LA 
contractile function is early in the order of spontaneous conversion to sinus rhythm > 
pharmacological defibrillation > electrical defibrillation. AF patients with normal LA size are 
also apt to show earlier LA functional recovery (Mattioli et al, 1998; Khan, 2003). 
Thromboembolic event is a major complication of AF. This complication after defibrillation has 
been attributed to the dislodgement of LA thrombi during the recovery from LA stunning. 
Therefore, serial echocardiographic investigation and optimal anticoagulation treatment are 
necessary during this period. LA stunning is observed also in the case of AF treated with 
radiofrequency catheter ablation. Stavrakis et al (2011) investigated the acute changes of LA 
function and PVF pattern following PV isolation associated with ganglionated plexi ablation 
by TEE. They reported augmentation of both D and S waves, decrease of S/D ratio, and trend 
toward an increase in LA appendage emptying velocities after the ablation. LA appendage 
emptying velocity closely relates to LA stunning, and reduced S/D ratio reflects impaired LA 
relaxation in the postablative period. These TEE findings are consistent with those reported by 
Lindgren et al (2003) in the paroxysmal interval of AF patients. 
ECG
UCG
RVOT
Ao
LA
P
Q
R
S
T
LADa LADd LADs
 
Fig. 8. Schematic illustration of the M-mode estimation of left atrial (LA) contractile 
function. LA dimension is variable depending on cardiac cycle. LADa, LA dimension 
immediately prior to the onset of LA contraction; LADd, minimal LA dimension at the end 
of the active LA contraction; LADs, maximal LA dimension at the end-systole. LA fractional 
shortening (LAFS) is calculated by equation (1) in the text. LA plays three kinds of 
hemodynamic function during an entire cardiac cycle (text). Aortic valve opening time 
corresponds to the left ventricular ejection period. Ao, aortic root; ECG, electrocardiogram; 
RVOT, right ventricular outflow tract; UCG, ultrasound cardiogram. 
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7. PVF in AF management 
Pharmacological AF management is mainly divided into rhythm control and rate control 
strategies, both of which show equivalent outcomes in long-term prognosis of AF patients 
provided that appropriate anticoagulation therapy is conducted (Wyse, 2005). However, 
choice of better strategy based only on electrophysiologic or electrocardiographic 
perspectives seems insufficient. PVF evaluation has the potential to play a role in this 
decision-making process, i.e., PVF recording enables evaluation of contractile LA and PV 
functions, which vary during the long period of AF remodeling affecting both LA and PV. 
For AF management, it is important to assess the stage of AF progression in individual AF 
patient with different clinical background. For this purpose, assessment of LA stiffness or 
contractility and severity of PV regurgitation by PVF profile is important for AF 
management in individual patient. 
Radiofrequency catheter ablation is widely conducted in many electrophysiologic 
laboratories. It is a first line therapy for ‘focal’ AF originating from PV, and is currently 
applied not only to paroxysmal AF but also to persistent AF. Remodeling makes AF drug-
refractory. Moreover, antiarrhythmic drugs often suppress cardiac performance (negative 
inotropism) and are sometimes arrhythmogenic (proarrhythmic effects). The main  
 
Fig. 9. Receiver-operating curve (ROC) discriminated PV backflow velocity (PVBV) as the 
best predictor of the progression of AF.  Areas under the ROC for PVBV, left atrial fractional 
shortening (LAFS) and left atrial diameter at end-diastole (LADd) are 0.873, 0.740 and 0.623, 
respectively. Cut-off PVBV for predicting future AF perpetuation is 21.8 cm/sec (sensitivity 
84.6%, specificity 78.3%). LAFS is calculated by equation (1) in the text. (From Maruyama, T.; 
Kishikawa, T.; Ito, H.; Kaji, Y.; Sasaki, Y. & Ishihara, Y. Augmentation of pulmonary vein 
backflow velocity during left atrial contraction: a novel phenomenon responsible for 
progression of atrial fibrillation in hypertensive patients. Cardiology Vol. 109, No. 1, 2008, pp. 
33-40, with permission.) 
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procedure for ablation is electrical isolation of PV-LA junctions, i.e., disconnection of 
arrhythmogenic PV and adjacent antrum. Although recent advance in navigation system 
and new catheter device have enabled safe and effective PV isolation, PV stenosis remains a 
major complication especially of circumferential PV isolation. Pulmonary veno-occlusive 
syndrome associated with secondary pulmonary hypertension is a serious late-onset 
complication. During this procedure, mild-to-moderate forward PVF (e.g., S and D waves) 
acceleration is recorded, but this acceleration is transient and well tolerated (Ren et al., 2002). 
PVF monitoring is a practical and cost-effective method for early detection of this serious 
complication (Tabata et al., 2003; Bollmann 2007). When considering PVF is influenced by 
heart rate and autonomic tone (Ren et al., 2004), computed tomography or MR imaging is 
required to determine the therapeutic indication for balloon dilatation of PV stenosis. 
8. PVF and AF progression 
All the components of PVF have the potential role to evaluate AF progression, i.e., S wave 
attenuation and consequent relative D wave augmentation indicate impaired LA relaxation 
and compliance. Considering increased D and Ar wave amplitudes during sinus rhythm in 
AF patients, PVF increases exclusively during LV diastole, whichever PVF direction is 
forward (e.g., D wave) or backward (e.g., Ar wave). If ectopic beats originating from PV are 
mechanically triggered, these echocardiographic findings indicate that ectopic beats are 
prone to occur during diastole. Therefore, repetitive PV ectopic beats easily capture 
ventricles that are out of refractory period, and induce rapid ventricular response during 
‘focal’ AF. This is important because rapid AF is easy to promote electrical remodeling 
(Wijffels et al., 1995). 
PV backflow during 
LA contraction        
loss of regular 
‘sphincter’ function
cyclic stretch of
PV musculature
repetitive or fibrillatory
electrical firing
progression of AF     
Vicious Cycle
 
Fig. 10. Possible mechanisms of reversed PV flow (Ar wave) augmentation contributing to 
the AF progression. 
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AF progression is reported to be associated with greater PV diameter (Knackstedt et al., 
2003; Tsao et al., 2001) as a consequence of PV remodeling (Scharf et al., 2003). Although the 
relation of AF and PV contraction remains to be fully investigated, augmentation of Ar wave 
(e.g., PVBV) may cause cyclic stretching of highly compliant myocardial sleeves in PV, 
repetitive ectopic beats and loss of ‘sphincter’ function, which underlie further PV 
regurgitation. Therefore, D and Ar waves augmentation, PV myocardial sleeve stretching 
and ectopic beats form a vicious cycle leading to PV remodeling. A possible mechanism by 
which PV characteristics contribute to AF progression is demonstrated in Fig. 10. 
9. Conclusion 
AF is the most common clinical arrhythmia showing progressive features. There has been 
evidence to suggest PV as a source of abnormal electrical activities initiating and sustaining 
AF. Currently, PVF recording is feasible in routine Doppler echocardiography, and is 
essential for evaluation of LA functioning three roles during an entire cardiac cycle such as 
‘booster pump’, ‘reservoir’ and ‘conduit’. This flow pattern recognition is of clinical 
importance not only in assessing global cardiac performance but also for obtaining 
considerable information with respect to the pathophysiology and management of AF. 
There has been a consensus with respect to the PVF pattern during ongoing AF or in 
patients with permanent AF. However, there has been a controversy concerning PVF profile 
during sinus rhythm in patients with paroxysmal AF. This indicates the anatomical and 
pathophysiological complexities of PV-LA junction and AF itself. Time-dependent recovery 
of LA contractile function (LA stunning) and neuroanatomical modification of PV-LA 
junction by radiofrequency catheter ablation make this controversy further complicated. In 
spite of such controversy and complexity, PVF recording has potential benefits to assess 
various stages of long-term AF progression and to manage the AF patients. 
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